M. Hattori et al., BROADLY REACTIVE ANTIBODIES TO HYPERVARIABLE REGION 1 IN HEPATITIS-C VIRUS-INFECTED PATIENT SERA - RELATION TO VIRAL LOADS AND RESPONSE TO INTERFERON, Hepatology, 27(6), 1998, pp. 1703-1710
To clarify the nature of serum anti-hypervariable region 1 (HVR1) anti
bodies in patients infected with hepatitis C virus (HCV), we assessed
the reactivity of 21 patients' sera with 42 HVR1 proteins by Western b
lot. HVR1 was expressed as fusion proteins with glutathione S-transfer
ase (GST), The patients' sera reacted with variable percentages of the
HVR1 proteins, and always reacted with HVR1 proteins of the different
genotype. In the genotype-1b-infected patients, the percentage of gen
otype-lb HVR1 proteins reactive with serum correlated significantly wi
th viral loads; the sera reactive with the higher percentages of HVR1
proteins contained the larger viral loads. In addition, it was signifi
cantly lower in the responders of interferon (IFN) therapy than in non
responders. The competition assays indicated that multiple fractions o
f anti-HVR1 antibodies with different specificity in a serum reacted w
ith different HVR1 proteins, and that, additionally, a single fraction
of antibodies often reacted with more than one HVR1 protein through a
similar amino acid sequence. In conclusion, serum anti-HVR1 antibodie
s were broadly reactive by the mechanism of both the cross-reactivity
of a single fraction of anti-HVR1 antibodies with more than one HVR1 p
rotein and the presence of multiple fractions of anti-HVR1 antibodies
with different specificity in a serum. In genotype-1b-infected patient
s, the broad reactivity of serum anti-HVR1 antibodies correlated with
viral loads and response to IFN. Further studies are necessary to eluc
idate the correlation among the broad reactivity of sera with multiple
HVR1 proteins and clinical features of chronic hepatitis C patients.